Characterizing the impact of intracutaneous dissemination on host responses during Borrelia burgdorferi infection
-
By
-
Samantha Crane
-
Amira-Nuriya McKinney
-
Clayton Jarrett
-
Chad S. Clancy
-
Olof Rickard Nilsson
-
Kelly L. Hawley
-
Ashley M. Groshong
-
June 5, 2026
-
Clinical Scorecard: Analyzing the Effects of Intracutaneous Spread on Host Immune Responses in Borrelia burgdorferi Infection
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Intracutaneous dissemination, immune response modulation, and MyD88 signaling involvement |
| Target Population | |
| Care Setting | |
Key Highlights
- OppA2 mutant shows restricted intracutaneous dissemination compared to wild-type.
- Dampened antibody responses observed in oppA2 mutant infections.
- Lymphatic dissemination is implicated in eventual organ colonization.
- MyD88 signaling plays a role in controlling spirochete dissemination.
- Systemic dissemination is critical for robust immune response.
- Immune evasion mechanisms contribute to dissemination.
Guideline-Based Recommendations
Diagnosis
- Utilize longitudinal infection models for evaluation.
- Consider specific diagnostic tests such as serology or PCR for Borrelia burgdorferi.
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Not applicable; study conducted in mouse models.
Understanding immune response dynamics may inform treatment strategies.
Clinical Best Practices
- Monitor for signs of systemic dissemination in Lyme disease.
- Evaluate immune response in patients with suspected Borrelia burgdorferi infection, focusing on antibody levels and immune cell populations.
Related Resources & Content
